GEN three-lens brief
Evidence-based stock research on GEN. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved +3.09% yesterday. · Debt-to-equity of 363.4 — balance-sheet-heavy.
- Moved +3.09% yesterday.
- Analyst mean target $30.01 — 32% above current (9 analysts).
- Debt-to-equity of 363.4 — balance-sheet-heavy.
GEN closed at $22.72 (+3.09%) as of 2026-05-13. Market cap: $13.76B. P/E (trailing) 14.5. Positives: moved +3.09% yesterday.; analyst mean target $30.01 — 32% above current (9 analysts).. Concerns: debt-to-equity of 363.4 — balance-sheet-heavy.. Last quarter: Revenue $1.24B, net income $192.00M, free cash flow $1.32B.
Why three lenses on GEN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine GENacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/GEN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath GEN brief"></iframe>